We are live on ! Find out more
PIA

Perennial Investment Advisors Portfolio holdings

AUM $1.26B
1-Year Est. Return 22.26%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+22.26%
3 Year Est. Return
+68.4%
5 Year Est. Return
+86.42%
10 Year Est. Return
AUM
$253M
AUM Growth
+$19.7M
Cap. Flow
+$14.5M
Cap. Flow %
5.72%
Top 10 Hldgs %
43.4%
Holding
218
New
40
Increased
79
Reduced
62
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 24.7%
2 Consumer Discretionary 11.49%
3 Financials 10.29%
4 Communication Services 6.46%
5 Consumer Staples 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
151
Chevron
CVX
$386B
$270K 0.11%
+2,573
New +$251K
AMBA icon
152
Ambarella
AMBA
$3.66B
$265K 0.1%
+2,640
New +$287K
VLUE icon
153
iShares MSCI USA Value Factor ETF
VLUE
$9.59B
$261K 0.1%
2,546
+98
+4% +$9.44K
ESGD icon
154
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
$258K 0.1%
+3,394
New +$256K
IGSB icon
155
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$257K 0.1%
4,707
+574
+14% +$31.5K
C icon
156
Citigroup
C
$231B
$255K 0.1%
3,506
-419
-11% -$28K
EL icon
157
Estee Lauder
EL
$31.7B
$254K 0.1%
873
-8
-0.9% -$2.19K
GDEN
158
DELISTED
Golden Entertainment
GDEN
$253K 0.1%
10,000
MTUM icon
159
iShares MSCI USA Momentum Factor ETF
MTUM
$26B
$253K 0.1%
+1,575
New +$260K
BL icon
160
BlackLine
BL
$1.65B
$250K 0.1%
+2,305
New +$287K
MCD icon
161
McDonald's
MCD
$195B
$249K 0.1%
1,109
ZBRA icon
162
Zebra Technologies
ZBRA
$17.9B
$243K 0.1%
500
-100
-17% -$44.6K
YARW
163
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$240K 0.09%
+39
New +$283K
LQD icon
164
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
$239K 0.09%
1,840
-2,482
-57% -$330K
PENN icon
165
PENN Entertainment
PENN
$2.57B
$236K 0.09%
+2,247
New +$249K
ABT icon
166
Abbott
ABT
$192B
$234K 0.09%
+1,950
New +$231K
JMIA
167
Jumia Technologies
JMIA
$793M
$233K 0.09%
+6,570
New +$315K
ABB
168
DELISTED
ABB Ltd
ABB
$225K 0.09%
7,370
+210
+3% +$6.3K
ACN icon
169
Accenture
ACN
$110B
$223K 0.09%
806
+27
+3% +$6.98K
MRNA icon
170
Moderna
MRNA
$25.4B
$223K 0.09%
+1,702
New +$247K
COP icon
171
ConocoPhillips
COP
$153B
$222K 0.09%
+4,183
New +$206K
WYNN icon
172
Wynn Resorts
WYNN
$10.6B
$221K 0.09%
+1,759
New +$212K
BMY icon
173
Bristol-Myers Squibb
BMY
$130B
$216K 0.09%
3,420
-494
-13% -$30.7K
FSKR
174
DELISTED
FS KKR Capital Corp. II
FSKR
$216K 0.09%
11,054
-1,594
-13% -$28.9K
VEA icon
175
Vanguard FTSE Developed Markets ETF
VEA
$238B
$215K 0.08%
4,372
+100
+2% +$4.88K

Similar funds

Perennial Investment Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Perennial Investment Advisors held 218 positions worth $253M, up 8.5% from $234M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Perennial Investment Advisors deployed $14.5M of net new capital in Q1 2021, opening 40 new positions and adding to 79 existing holdings. Its largest new stake was First Trust Large Cap Growth AlphaDEX Fund: 10,214 shares worth $997K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $957K trimmed.

  • Perennial Investment Advisors's largest Q1 2021 buy was First Trust Large Cap Growth AlphaDEX Fund: 10,214 shares worth $997K.
  • Perennial Investment Advisors added most to iShares Core Dividend Growth ETF in Q1 2021, an estimated $1.25M increase.
  • Perennial Investment Advisors's biggest Q1 2021 reduction was Advanced Micro Devices, cutting an estimated $957K.
  • Perennial Investment Advisors fully exited Velodyne Lidar, Inc. Common Stock in Q1 2021, selling an estimated $787K.
  • Perennial Investment Advisors's ten largest holdings make up 43% of its $253M portfolio in Q1 2021.
  • Perennial Investment Advisors opened 40 new positions and closed 16 in Q1 2021.
  • Perennial Investment Advisors's portfolio value rose 8.5% quarter-over-quarter to $253M.

Based on Perennial Investment Advisors's 13F filing for Q1 2021, filed 29 Apr 2021.